184 related articles for article (PubMed ID: 16401677)
1. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.
Helske S; Syväranta S; Kupari M; Lappalainen J; Laine M; Lommi J; Turto H; Mäyränpää M; Werkkala K; Kovanen PT; Lindstedt KA
Eur Heart J; 2006 Jun; 27(12):1495-504. PubMed ID: 16401677
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves.
Helske S; Laine M; Kupari M; Lommi J; Turto H; Nurmi L; Tikkanen I; Werkkala K; Lindstedt KA; Kovanen PT
Eur Heart J; 2007 Aug; 28(15):1894-903. PubMed ID: 17507367
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis.
Syväranta S; Helske S; Laine M; Lappalainen J; Kupari M; Mäyränpää MI; Lindstedt KA; Kovanen PT
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1220-7. PubMed ID: 20299690
[TBL] [Abstract][Full Text] [Related]
4. Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart.
Jahanyar J; Youker KA; Loebe M; Assad-Kottner C; Koerner MM; Torre-Amione G; Noon GP
J Surg Res; 2007 Jun; 140(2):199-203. PubMed ID: 17418861
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cigarette smoke on the expression of transforming growth factor-beta1 mRNA and collagen type III in airways of asthmatic rats].
Guo ZH; DU YC; Xu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):42-5. PubMed ID: 18366906
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.
Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655
[TBL] [Abstract][Full Text] [Related]
8. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
Shan H; Zhang Y; Lu Y; Zhang Y; Pan Z; Cai B; Wang N; Li X; Feng T; Hong Y; Yang B
Cardiovasc Res; 2009 Aug; 83(3):465-72. PubMed ID: 19398468
[TBL] [Abstract][Full Text] [Related]
11. Induction of local angiotensin II-producing systems in stenotic aortic valves.
Helske S; Lindstedt KA; Laine M; Mäyränpää M; Werkkala K; Lommi J; Turto H; Kupari M; Kovanen PT
J Am Coll Cardiol; 2004 Nov; 44(9):1859-66. PubMed ID: 15519020
[TBL] [Abstract][Full Text] [Related]
12. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.
Gebhardt T; Lorentz A; Detmer F; Trautwein C; Bektas H; Manns MP; Bischoff SC
Gut; 2005 Jul; 54(7):928-34. PubMed ID: 15951536
[TBL] [Abstract][Full Text] [Related]
13. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts.
Dai HY; Kang WQ; Wang X; Yu XJ; Li ZH; Tang MX; Xu DL; Li CW; Zhang Y; Ge ZM
Regul Pept; 2007 Apr; 140(1-2):88-93. PubMed ID: 17188370
[TBL] [Abstract][Full Text] [Related]
14. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
[TBL] [Abstract][Full Text] [Related]
16. Activity and localization of cathepsin B, D and G in aortic aneurysm.
Gacko M; Chyczewski L
Int Surg; 1997; 82(4):398-402. PubMed ID: 9412840
[TBL] [Abstract][Full Text] [Related]
17. [Role of mast cells in the development of renal interstitial fibrosis in children with Henoch-Schonlein purpura nephritis].
Zhang GP; Dang XQ; Yi ZW; He XJ; Zhang JJ; Wu XC; Mo SH
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):125-8. PubMed ID: 17448307
[TBL] [Abstract][Full Text] [Related]
18. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
[TBL] [Abstract][Full Text] [Related]
19. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
20. [Application of transforming growth factor-beta(1) on construction of tissue engineering heart valves: experimental in vitro].
Dong NG; Qiu YM; Shi JW
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1622-6. PubMed ID: 17803853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
